Fonte: Neuro-Oncology. Nome do evento: Annual Scientific Meeting of the Society for Neuro-Oncology. Unidade: FMRP
Assuntos: METILAÇÃO DE DNA, GLIOMA, DNA, GENOMAS
ABNT
MALTA, Tathiane et al. Epigenomic (DNA methylation and expression) signatures define subsets of both IDHmut and IDHwt glioma with distinct clinical outcomes. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/nov214.14. Acesso em: 30 set. 2024. , 2015APA
Malta, T., Sabedot, T., Ceccarelli, M., Barthel, F., Pagnotta, S., Lavarone, A., et al. (2015). Epigenomic (DNA methylation and expression) signatures define subsets of both IDHmut and IDHwt glioma with distinct clinical outcomes. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/nov214.14NLM
Malta T, Sabedot T, Ceccarelli M, Barthel F, Pagnotta S, Lavarone A, Verhaak R, Noushmehr H. Epigenomic (DNA methylation and expression) signatures define subsets of both IDHmut and IDHwt glioma with distinct clinical outcomes [Internet]. Neuro-Oncology. 2015 ; 17[citado 2024 set. 30 ] Available from: https://doi.org/10.1093/neuonc/nov214.14Vancouver
Malta T, Sabedot T, Ceccarelli M, Barthel F, Pagnotta S, Lavarone A, Verhaak R, Noushmehr H. Epigenomic (DNA methylation and expression) signatures define subsets of both IDHmut and IDHwt glioma with distinct clinical outcomes [Internet]. Neuro-Oncology. 2015 ; 17[citado 2024 set. 30 ] Available from: https://doi.org/10.1093/neuonc/nov214.14